LOS ANGELES -- U.S. regulators issued new guidance this week shortening the time that people who received Moderna or Pfizer's COVID-19 vaccine have to wait for a booster, and it's different than the ...

As the new coronavirus burns its way across the world, scientists are rushing to find ways to identify those who have been infected — including those who have recovered from COVID-19. Those people, ...

An international research consortium, led by scientists at VIB and UGent, has developed a new platform that could change how antibody medicines are tested and brought to patients. The work, published ...

NEW YORK -- More than 90% of U.S. adults remain susceptible to COVID-19, according to research published on Friday. Using data from dialysis centers in the United States, the study, published in The ...

A new human monoclonal antibody moves a step closer to a universal antibody cocktail that works against all strains of SARS-CoV-2. SARS-CoV-2, the virus that causes COVID-19 disease, continues to ...

The hepatitis A virus (HAV) antibody (AB) total test identifies both types of antibodies that the body produces in response to HAV infection. A reactive result means the test has detected HAV ...

Split-virus influenza vaccines may increase pre-existing neuraminidase inhibition antibody titers in adults up to 6 months postvaccination.

Scientists at the Icahn School of Medicine at Mount Sinai have identified an important immune response that helps explain why ...